Cardiomyocyte Ca 2+ homeostasis as a therapeutic target in heart failure with reduced and preserved ejection fraction-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cardiomyocyte Ca 2+ homeostasis as a therapeutic target in heart failure with reduced and preserved ejection fraction

Published:2017-04 Issue: Volume:33 Page:17-26
ISSN:1471-4892
Container-title:Current Opinion in Pharmacology
language:en
Short-container-title:Current Opinion in Pharmacology

Author:

Peana Deborah,Domeier Timothy L.

Funder

The National Institutes of Health

University of Missouri Research Board

Missouri School of Medicine Research Fellowship

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference58 articles.

1. Forecasting the impact of heart failure in the United States a policy statement from the American Heart Association;Heidenreich;Circ. Heart Fail.,2013

2. Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap;Shah;Circulation,2016

3. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology;Paulus;Eur. Heart J.,2007

4. Heart failure with preserved ejection fraction mechanisms, clinical features, and therapies;Sharma;Circ. Res.,2014

5. Cardiac excitation-contraction coupling;Bers;Nature,2002

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of a new model of chemotherapy-induced heart failure with reduced ejection fraction and nephrotic syndrome in Ren-2 transgenic rats;Hypertension Research;2024-09-09

2. IL‐37 Modulates Myocardial Calcium Handling via the p‐STAT3/SERCA2a Axis in HF‐Related Engineered Human Heart Tissue;Advanced Healthcare Materials;2024-02-19

3. Tumor Necrosis Factor-α Mediates Inflammation-induced Early-Stage Left Ventricular Systolic Dysfunction;Journal of Cardiovascular Pharmacology;2023-06

4. SGLT2 Inhibition in Heart Failure with Preserved Ejection Fraction — The New Frontier;Reviews in Cardiovascular Medicine;2023-01-03

5. New Opportunities in Heart Failure with Preserved Ejection Fraction: From Bench to Bedside… and Back;Biomedicines;2022-12-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3